Cited by 437Multiple Sclerosis Research StudiesPregnancy and Medication ImpactPsoriasis: Treatment and Pathogenesis

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Treatment of multiple sclerosis with the pregnancy hormone estriol

Sicotte, Nancy L., Liva, Stephanie M., Klutch, Rochelle, Pfeiffer, Paul, Bouvier, Seth, Odesa, Sylvia, Wu, T. C. Jackson, Voskuhl, Rhonda R.·2002·Annals of Neurology

DOI 10.1002/ana.10301

Open this paper in CoChat — free account

Abstract

Multiple sclerosis patients who become pregnant experience a significant decrease in relapses that may be mediated by a shift in immune responses from T helper 1 to T helper 2. Animal models of multiple sclerosis have shown that the pregnancy hormone, estriol, can ameliorate disease and can cause an immune shift. We treated nonpregnant female multiple sclerosis patients with the pregnancy hormone estriol in an attempt to recapitulate the beneficial effect of pregnancy. As compared with pretreatment baseline, relapsing remitting patients treated with oral estriol (8mg/day) demonstrated significant decreases in delayed type hypersensitivity responses to tetanus, interferon‐γ levels in peripheral blood mononuclear cells, and gadolinium enhancing lesion numbers and volumes on monthly cerebral magnetic resonance images. When estriol treatment was stopped, enhancing lesions increased to pretreatment levels. When estriol treatment was reinstituted, enhancing lesions again were significantly decreased. Based on these results, a larger, placebo‐controlled trial of estriol is warranted in women with relapsing remitting multiple sclerosis. This novel treatment strategy of using pregnancy doses of estriol in multiple sclerosis has relevance to other autoimmune diseases that also improve during pregnancy.

Integrity signals

Registry

Crossref · 10.1002/ana.10301

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?
Wegmann, T. G., Lin, H., Guilbert, L., & Mosmann, T. R. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90235-d · Cited by 2,852
Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis
Paty, D. W., Li, D. K. B., the UBC MS/MRI Study Group, & the IFNB Multiple Sclerosis Study Group (1993) · Neurology · doi:10.1212/wnl.43.4.662 · Cited by 1,964
Rate of Pregnancy-Related Relapse in Multiple Sclerosis
Confavreux, C., Hutchinson, M., Hours, M. M., Cortinovis-Tourniaire, P., & Moreau, T. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807303390501 · Cited by 1,559
Immunological Aspects Of Demyelinating Diseases
Martinꝉ, R., McFarland, H. F., & McFarlin, D. E. (1992) · Annual Review of Immunology · doi:10.1146/annurev.iy.10.040192.001101 · Cited by 1,021
European/Canadian multicenter, double‐blind, randomized, placebo‐controlled study of the effects of glatiramer acetate on magnetic resonance imaging–measured disease activity and burden in patients with relapsing multiple sclerosis
Comi, G., Filippi, M., Wolinsky, J. S., & European/Canadian Glatiramer Acetate Study Group (2001) · Annals of Neurology · doi:10.1002/ana.64 · Cited by 768
European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging--measured disease activity and burden in patients with relapsing multiple sclerosis. European/Canadian Glatiramer Acetate Study Group.
Comi, G., Filippi, M., & Wolinsky, J. S. (2001) · PubMed · Cited by 688
Randomized controlled trial of interferon-beta-1a in secondary progressive MS
Li, D. K. B., Zhao, G., & Paty, D. W. (2001) · Neurology · doi:10.1212/wnl.56.11.1505 · Cited by 458
Glatiramer acetate (Copaxone®) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis
Duda, P. W., Schmied, M. C., Cook, S. L., Krieger, J. I., & Hafler, D. A. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8970 · Cited by 416
Testosterone Acts Directly on CD4+ T Lymphocytes to Increase IL-10 Production
Liva, S. M., & Voskuhl, R. R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.4.2060 · Cited by 395
Self-citation
Using gadolinium‐enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis
McFarland, H. F., Frank, J. A., Albert, P. S., Smith, M. E., Martinꝉ, R., Harris, J. O., Patronas, N. J., Maloni, H. W., & McFarlin, D. E. (1992) · Annals of Neurology · doi:10.1002/ana.410320609 · Cited by 347

Show all 41 references

Sorted by citations

Items 101–200 of 437

Specific estrogen sulfotransferase (SULT1E1) substrates and molecular imaging probe candidates
Cole, G. B., Keum, G., Liu, J., Small, G. W., Satyamurthy, N., Kepe, V., & Barrio, J. R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914904107 · Cited by 73
Parity and secondary progression in multiple sclerosis
Koch, M. W., Uyttenboogaart, M., Heersema, D. J., Steen, C. B., & Keyser, J. D. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.160911 · Cited by 72
T helper cell immunity in pregnancy and influence on autoimmune disease progression
Graham, J. J., Longhi, M. S., & Heneghan, M. A. (2021) · Journal of Autoimmunity · doi:10.1016/j.jaut.2021.102651 · Cited by 77
Treatment with selective estrogen receptor modulators regulates myelin specific T‐cells and suppresses experimental autoimmune encephalomyelitis
Bebo, B. F., Dehghani, B., Foster, S. C., Kurniawan, A., López, F. J., & Sherman, L. S. (2008) · Glia · doi:10.1002/glia.20805 · Cited by 74
Increased Mortality for Neurological and Mental Diseases following Early Bilateral Oophorectomy
Rivera, C. M., Grossardt, B. R., Rhodes, D. J., & Rocca, W. A. (2009) · Neuroepidemiology · doi:10.1159/000211951 · Cited by 71
Estrogen Mediates Innate and Adaptive Immune Alterations to Influenza Infection in Pregnant Mice
Pazos, M. A., Kraus, T., Muñoz‐Fontela, C., & Moran, T. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040502 · Cited by 70
Toward the development of rational therapies in multiple sclerosis: what is on the horizon?
Hemmer, B., & Hartung, H. (2007) · Annals of Neurology · doi:10.1002/ana.21289 · Cited by 70
Impact of natural menopause on multiple sclerosis: a multicentre study
Baroncini, D., Annovazzi, P. O. L., Rossi, N. D., Mallucci, G., Clerici, V. T., Tonietti, S., Mantero, V., Ferrò, M. T., Messina, M., Barcella, V., et al. (2019) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-320587 · Cited by 70
Antigen-specific T cell functions are suppressed over the estrogen-dendritic cell-indoleamine 2,3-dioxygenase axis
Xiao, B., Liu, X., & Link, H. (2004) · Steroids · doi:10.1016/j.steroids.2004.05.019 · Cited by 67
Female reproductive issues in multiple sclerosis
McCombe, P., & Greer, J. M. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458512452331 · Cited by 67
Targeting Nuclear Receptors in Neurodegeneration and Neuroinflammation
Willems, S., Zaienne, D., & Merk, D. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00186 · Cited by 66
Disease-Modifying Agents for Multiple Sclerosis
Menge, T., Weber, M. S., Hemmer, B., Kieseier, B. C., von Büdingen, H. ‐., Warnke, C., Zamvil, S. S., Boster, A. L., Khan, O., Hartung, H. P., et al. (2008) · Drugs · doi:10.2165/0003495-200868170-00004 · Cited by 66
Reproductive organ involvement in non-Hodgkin lymphoma during pregnancy: a systematic review
Horowitz, N. A., Benyamini, N., Wohlfart, K., Brenner, B., & Avivi, I. M. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70589-2 · Cited by 66
Sex Hormones and Optic Nerve Disorders: A Review
Nuzzi, R., Scalabrin, S., Becco, A., & Panzica, G. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00057 · Cited by 66
Hormonal and gender-related immune changes in multiple sclerosis
Airas, L. M. (2015) · Acta Neurologica Scandinavica · doi:10.1111/ane.12433 · Cited by 67
Remyelination — An effective means of neuroprotection
Bruce, C. C., Zhao, C., & Franklin, R. J. M. (2009) · Hormones and Behavior · doi:10.1016/j.yhbeh.2009.06.004 · Cited by 65
A high throughput drug screening assay to identify compounds that promote oligodendrocyte differentiation using acutely dissociated and purified oligodendrocyte precursor cells
Lariosa-Willingham, K. D., Rosler, E. S., Tung, J. S., Dugas, J. C., Collins, T. L., & Leonoudakis, D. (2016) · BMC Research Notes · doi:10.1186/s13104-016-2220-2 · Cited by 65
IFNG polymorphisms are associated with gender differences in susceptibility to multiple sclerosis
Kantarci, O. H., Goris, A., Hebrink, D. D., Heggarty, S., Cunningham, S., Alloza, I., Atkinson, E. J., de Andrade, M., McMurray, C. T., Graham, C. A., et al. (2005) · Genes and Immunity · doi:10.1038/sj.gene.6364164 · Cited by 63
Fetal–Maternal Alignment of Regulatory T Cells Correlates with IL-10 and Bcl-2 Upregulation in Pregnancy
Santner‐Nanan, B., Straubinger, K., Hsu, P. S., Parnell, G. P., Tang, B., Xu, B., Makris, A., Hennessy, A., Peek, M. J., Busch, D. H., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203165 · Cited by 62
An overview of pregnancy‐related issues in patients with multiple sclerosis
Pozzilli, C., & Pugliatti, M. (2015) · European Journal of Neurology · doi:10.1111/ene.12797 · Cited by 62
Gut microbiome and the risk factors in central nervous system autoimmunity
Ochoa‐Repáraz, J., & Kasper, L. H. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.09.024 · Cited by 65
Protective autoimmunity in the nervous system
Graber, J. J., & Dhib-Jalbut, S. S. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.10.001 · Cited by 62
Pregnancy, postpartum and parity: Resilience and vulnerability in brain health and disease
Deems, N. P., & Leuner, B. (2020) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2020.100820 · Cited by 67
New and emerging treatment options for multiple sclerosis
Polman, C. H., & Uitdehaag, B. M. J. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00505-2 · Cited by 62
Reproductive history and progressive multiple sclerosis risk in women
Zeydan, B., Atkinson, E. J., Weis, D., Smith, C. Y., Rocca, L. G., Rocca, W. A., Keegan, B. M., Weinshenker, B. G., Kantarci, K., & Kantarci, O. H. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa185 · Cited by 61
Acute experimental autoimmune encephalomyelitis induces sex dimorphic changes in neuroactive steroid levels
Giatti, S., D’Intino, G., Maschi, O., Pesaresi, M., García‐Segura, L. M., Calzà, L., Caruso, D., & Melcangi, R. C. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.09.009 · Cited by 63
Curcumin as a therapeutic candidate for multiple sclerosis: Molecular mechanisms and targets
Ghanaatian, N., Lashgari, N., Abdolghaffari, A. H., Rajaee, S. M., Panahi, Y., Barreto, G. E., Butler, A. E., & Sahebkar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27965 · Cited by 60
Management strategies for female patients of reproductive potential with multiple sclerosis: An evidence-based review
Coyle, P. K., Oh, J., Magyari, M., Oreja‐Guevara, C., & Houtchens, M. K. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2019.04.003 · Cited by 59
Preliminary studies of cytokine secretion patterns associated with pregnancy in MS patients
Gilmore, W., Arias, M., Stroud, N., Stek, A. M., McCarthy, K. A., & Correale, J. D. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.06.011 · Cited by 60
Hormones in Wellness and Disease Prevention: Common Practices, Current State of the Evidence, and Questions for the Future
Schwartz, E., & Holtorf, K. (2008) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2008.07.015 · Cited by 59
Sex effects on inflammatory and neurodegenerative processes in multiple sclerosis
Ramien, C., Taenzer, A., Lupu, A., Heckmann, N., Engler, J. B., Patas, K., Friese, M. A., & Gold, S. M. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.12.015 · Cited by 59
PD-1 Interaction with PD-L1 but not PD-L2 on B-cells Mediates Protective Effects of Estrogen against EAE
Bodhankar, S. (2013) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000143 · Cited by 62
Neuroendocrine Immunoregulation in Multiple Sclerosis
Deckx, N., Lee, W.-P., Berneman, Z. N., & Cools, N. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/705232 · Cited by 62
Oestrogen treatment of experimental autoimmune encephalomyelitis requires 17β‐oestradiol‐receptor‐positive B cells that up‐regulate PD ‐1 on CD 4+ F oxp3+ regulatory T cells
Bodhankar, S., Vandenbark, A. A., & Offner, H. (2012) · Immunology · doi:10.1111/imm.12013 · Cited by 56
Hormonal Regulation of Oligodendrogenesis II: Implications for Myelin Repair
Breton, J., Long, K. L. P., Barraza, M., Perloff, O. S., & Kaufer, D. (2021) · Biomolecules · doi:10.3390/biom11020290 · Cited by 57
Estriol preserves synaptic transmission in the hippocampus during autoimmune demyelinating disease
Ziehn, M. O., Avedisian, A., Dervin, S., O'Dell, T., & Voskuhl, R. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.76 · Cited by 55
Self-citation
“Disease modifying nutricals” for multiple sclerosis
Schmitz, K., Barthelmes, J., Stolz, L., Beyer, S., Diehl, O., & Tegeder, I. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.015 · Cited by 55
Sex hormones, brain damage and clinical course of Multiple Sclerosis
Tomassini, V., & Pozzilli, C. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.04.014 · Cited by 54
Estriol: emerging clinical benefits
Ali, E., Mangold, C., & Peiris, A. N. (2017) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000855 · Cited by 54
Oestrogen receptor β ligand acts on CD11c+ cells to mediate protection in experimental autoimmune encephalomyelitis
Kim, R. Y., Mangu, D., Hoffman, A., Kavosh, R., Jung, E., Itoh, N., & Voskuhl, R. R. (2017) · Brain · doi:10.1093/brain/awx315 · Cited by 54
Self-citation
Dendritic cells exposed to estrogen in vitro exhibit therapeutic effects in ongoing experimental allergic encephalomyelitis
Pettersson, Å., Ciumas, C., Семёнович, Ч. В., Link, H., Huang, Y.-M., & Xiao, B. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.07.004 · Cited by 54
Effects of the Menstrual Cycle on Neurological Disorders
Roeder, H. J., & Leira, E. C. C. (2021) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-021-01115-0 · Cited by 53
Sex-Based Differences in Multiple Sclerosis (MS): Part II: Rising Incidence of Multiple Sclerosis in Women and the Vulnerability of Men to Progression of this Disease
Dunn, S. E., Gunde, E., & Lee, H. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_370 · Cited by 57
Vitamin D treatment in multiple sclerosis
Myhr, K. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.05.002 · Cited by 53
Long-term influence of combined oral contraceptive use on the clinical course of relapsing–remitting multiple sclerosis
Gava, G., Bartolomei, I., Costantino, A., Berra, M., Venturoli, S., Salvi, F., & Meriggiola, M. C. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.03.054 · Cited by 52
Testosterone and estrogen in multiple sclerosis: from pathophysiology to therapeutics
Collongues, N., Patte‐Mensah, C., Seze, J. D., Mensah‐Nyagan, A. G., & Derfuss, T. J. (2018) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2018.1481390 · Cited by 52
Hormonal influences in multiple sclerosis: New therapeutic benefits for steroids
El‐Etr, M., Ghoumari, A. M., Sitruk-Ware, R. L., & Schumacher, M. (2010) · Maturitas · doi:10.1016/j.maturitas.2010.09.014 · Cited by 53
A putative mechanism on remission of multiple sclerosis during pregnancy: estrogen-induced indoleamine 2,3-dioxygenase by dendritic cells
Zhu, W.-H., Lu, C.-Z., Huang, Y.-M., Link, H., & Xiao, B.-G. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458506071171 · Cited by 50
Pregnancy and multiple sclerosis
Lee, M., & O’Brien, P. (2008) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.116947 · Cited by 49
The Adaptive Immune System in Multiple Sclerosis: An Estrogen-Mediated Point of View
Maglione, A., Rolla, S., Mercanti, S. F. D., Cutrupi, S., & Clerico, M. (2019) · Cells · doi:10.3390/cells8101280 · Cited by 48
Postpartum-activation of multiple sclerosis is associated with down-regulation of tolerogenic HLA-G
Airas, L. M., Nikula, T., Huang, Y., Lahesmaa, R., & Wiendl, H. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.05.008 · Cited by 48
Geoepidemiology of COPD and idiopathic pulmonary fibrosis
Zeki, A. A., Schivo, M., Chan, A. L., Hardin, K. A., Kenyon, N. J., Albertson, T. E., Rosenquist, G. L., & Louie, S. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.11.004 · Cited by 48
Potential scope of action of tissue kallikreins in CNS immune-mediated disease
Scarisbrick, I. A., Blaber, S. I., Tingling, J. T., Rodriguez, M., Blaber, M., & Christophi, G. P. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.05.022 · Cited by 48
The influence of sex hormones on cytokines in multiple sclerosis and experimental autoimmune encephalomyelitis: a review
van den Broek, H. H., Damoiseaux, J. G. M. C., Baets, M. H. D., & Hupperts, R. (2005) · Multiple Sclerosis Journal · doi:10.1191/1352458505ms1174rr · Cited by 47
Gender issues and multiple sclerosis
Voskuhl, R. R. (2002) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-002-0087-1 · Cited by 48
Self-citation
Sex-hormone receptors pattern on regulatory T-cells: clinical implications for multiple sclerosis
Aristimuño, C., Teijeiro, R., Valor, L., Alonso, B., Tejera‐Alhambra, M., de Andrés, C., Oliver‐Miñarro, D., Lazareno, N. L., Faure, F., & Sánchez‐Ramón, S. (2012) · Clinical and Experimental Medicine · doi:10.1007/s10238-011-0172-3 · Cited by 47
Endogenous estrogens, through estrogen receptor α, constrain autoimmune inflammation in female mice by limiting CD4 + T‐cell homing into the CNS
Lélu, K., Delpy, L., Robert, V., Foulon, E., Laffont, S., Pelletier, L., Engelhardt, B., & Guéry, J. (2010) · European Journal of Immunology · doi:10.1002/eji.201040678 · Cited by 46
Treatment trials in progressive MS—current challenges and future directions
Koch, M. W., Cutter, G., Stys, P. K., Yong, V. W., & Metz, L. M. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.148 · Cited by 46
Increase in chemokine CXCL1 by ERβ ligand treatment is a key mediator in promoting axon myelination
Karim, H., Kim, S. H., Lapato, A. S., Yasui, N., Katzenellenbogen, J. A., & Tiwari-Woodruff, S. K. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1721732115 · Cited by 45
Uses of Complementary and Alternative Medicine in Multiple Sclerosis
Namjooyan, F., Ghanavati, R., Majdinasab, N., Jokari, S., & Janbozorgi, M. (2014) · Journal of Traditional and Complementary Medicine · doi:10.4103/2225-4110.136543 · Cited by 45
Nudging oligodendrocyte intrinsic signaling to remyelinate and repair: Estrogen receptor ligand effects
Khalaj, A. J., Hasselmann, J., Augello, C. J., Moore, S. M., & Tiwari-Woodruff, S. K. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.01.006 · Cited by 46
Pregnancy and multiple sclerosis: from molecular mechanisms to clinical application
Gold, S. M., & Voskuhl, R. R. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-016-0584-y · Cited by 44
Self-citation
Bedside to bench to bedside research: Estrogen receptor beta ligand as a candidate neuroprotective treatment for multiple sclerosis
Itoh, N., Kim, R. Y., Peng, M. S., DiFilippo, E., Johnsonbaugh, H. B., MacKenzie‐Graham, A. J., & Voskuhl, R. R. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.09.017 · Cited by 44
Self-citation
Pulmonary Infections in Pregnancy
Gupta, A., & Mathad, J. S. (2017) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0037-1602375 · Cited by 45
Mechanisms of sex hormones in autoimmunity: focus on EAE
Lasrado, N., Jia, T., Massilamany, C., Franco, R., Illés, Z., & Reddy, J. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00325-4 · Cited by 49
Sex Hormones as Key Modulators of the Immune Response in Multiple Sclerosis: A Review
Murgia, F., Giagnoni, F., Lorefice, L., Caria, P., Dettori, T., D’Alterio, M. N., Angioni, S. L., Hendren, A. J., Caboni, P., Pibiri, M., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10123107 · Cited by 45
FTY720 (fingolimod) treatment tips the balance towards less immunogenic antigen-presenting cells in patients with multiple sclerosis
Luessi, F., Kraus, S. H. P., Trinschek, B., Lerch, S., Ploen, R., Paterka, M., Roberg, T., Poisa-Beiro, L., Klotz, L., Wiendl, H., et al. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515574895 · Cited by 41
Sex-specific differences in retinal nerve fiber layer thinning after acute optic neuritis
Costello, F., Hodge, W., Pan, Y., Burton, J., Freedman, M. S., Stys, P. K., Trufyn, J., & Kardon, R. H. (2012) · Neurology · doi:10.1212/wnl.0b013e318271f755 · Cited by 41
Pregnancy and multiple sclerosis: the initial results from a Brazilian database
Fragoso, Y. D., Finkelsztejn, A., Comini-Frota, E. R., da Gama, P. D., Grzesiuk, A. K., Khouri, J. M. N., Alves‐Leon, S. V., Morales, R. R., Lana–Peixoto, M. A., & Rocha, C. F. (2009) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2009000400015 · Cited by 41
Management of multiple sclerosis: current trials and future options
Noseworthy, J. H. (2003) · Current Opinion in Neurology · doi:10.1097/01.wco.0000073929.19076.cd · Cited by 41
Female Gender and Reproductive Factors Affecting Risk, Relapses and Progression in Multiple Sclerosis
D'hooghe, M. B., D’Hooghe, T., & Keyser, J. D. (2013) · Gynecologic and Obstetric Investigation · doi:10.1159/000346319 · Cited by 40
Other therapy options and future strategies for treating patients with multiple sclerosis
Rizvi, S., & Bashir, K. (2004) · Neurology · doi:10.1212/wnl.63.12_suppl_6.s47 · Cited by 39
Foetal immune programming: hormones, cytokines, microbes and regulatory T cells
Hsu, P. S., & Nanan, R. K. H. (2014) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2014.02.005 · Cited by 38
Androgens show sex-dependent differences in myelination in immune and non-immune murine models of CNS demyelination
Zahaf, A., Kassoussi, A., Hutteau-Hamel, T., Mellouk, A., Marie, C., Zoupi, L., Tsouki, F., Mattern, C., Bobé, P., Schumacher, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36846-w · Cited by 37
PET imaging in multiple sclerosis
Faria, D. D. P., Copray, S. C. V. M., Buchpiguel, C. A., Dierckx, R., & de Vries, E. F. J. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9544-2 · Cited by 40
Testosterone Differentially Affects T Cells and Neurons in Murine and Human Models of Neuroinflammation and Neurodegeneration
Massa, M. G., David, C., Haase, S., Berg, J., Gisevius, B., Hirschberg, S., Linker, R. A., Gold, R., & Haghikia, A. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.03.006 · Cited by 36
Pregnancy Epigenetic Signature in T Helper 17 and T Regulatory Cells in Multiple Sclerosis
Iannello, A., Rolla, S., Maglione, A., Ferrero, G., Bardina, V., Inaudi, I., Mercanti, S. F. D., Novelli, F., D'Antuono, L., Cardaropoli, S., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03075 · Cited by 36
Mind over cytokines: Crosstalk and regulation between the neuroendocrine and immune systems
Miyake, S. (2011) · Clinical and Experimental Neuroimmunology · doi:10.1111/j.1759-1961.2011.00023.x · Cited by 36
Multiple sclerosis at menopause: Potential neuroprotective effects of estrogen
Christianson, M. S., Mensah, V. A., & Shen, W. (2014) · Maturitas · doi:10.1016/j.maturitas.2014.11.013 · Cited by 35
Estrogen Therapy Delays Autoimmune Diabetes and Promotes the Protective Efficiency of Natural Killer T-Cell Activation in Female Nonobese Diabetic Mice
Gourdy, P., Bourgeois, E. A., Levescot, A., Pham, L., Riant, É., Ahui, M. L. B., Damotte, D., Gombert, J., Bayard, F., Ohlsson, C., et al. (2015) · Endocrinology · doi:10.1210/en.2015-1313 · Cited by 35
Biochanin A Improves Memory Decline and Brain Pathology in Cuprizone-Induced Mouse Model of Multiple Sclerosis
Aldhahri, R. S., Alghamdi, B. S. A., Alzahrani, N. A., Bahaidrah, K. A., Alsufiani, H. M., Mansouri, R. A., & Ashraf, G. M. (2022) · Behavioral Sciences · doi:10.3390/bs12030070 · Cited by 35
Are multiple sclerosis patients risk-takers?
Hawkes, C. H. (2005) · QJM · doi:10.1093/qjmed/hci135 · Cited by 35
A correlation of pregnancy term, disease activity, serum female hormones, and cytokines in uveitis
Chan, C. (2004) · British Journal of Ophthalmology · doi:10.1136/bjo.2004.048595 · Cited by 35
Contraceptive use among women with multiple sclerosis: a systematic review
Zapata, L. B., Oduyebo, T., Whiteman, M. K., Houtchens, M. K., Marchbanks, P. A., & Curtis, K. M. (2016) · Contraception · doi:10.1016/j.contraception.2016.07.013 · Cited by 35
Pregnancy and Multiple Sclerosis
Bennett, K. (2005) · Clinical Obstetrics & Gynecology · doi:10.1097/01.grf.0000153881.20014.86 · Cited by 34
Hormone-based therapies in MS.
Voskuhl, R. R. (2003) · PubMed · Cited by 34
Self-citation
Suppression of the inflammatory response in experimental arthritis is mediated via estrogen receptor α but not estrogen receptor β
Dulos, J., Vijn, P. C. M., van Doorn, C., Hofstra, C. L., Veening-Griffioen, D. H., Graaf, J. D., Dijcks, F. A., & Boots, A. M. H. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3032 · Cited by 33
Disease-modifying therapies in multiple sclerosis: an update on recent and ongoing trials and future strategies
Wiendl, H., & Kieseier, B. C. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.4.689 · Cited by 33
Estrogen-mediated protection of experimental autoimmune encephalomyelitis: Lessons from the dissection of estrogen receptor-signaling in vivo
Guéry, J., Lélu, K., Laffont, S., & Garnier, L. (2015) · Biomedical Journal · doi:10.4103/2319-4170.158509 · Cited by 35
Estrogen receptor‐β ligand treatment after disease onset is neuroprotective in the multiple sclerosis model
Wisdom, A. J., Cao, Y., Itoh, N., Spence, R. D., & Voskuhl, R. R. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23219 · Cited by 32
Self-citation
Autoimmune Hepatitis: Tolerogenic Immunological State During Pregnancy and Immune Escape in Post-partum
Bozward, A. G., Wootton, G. E., Podstawka, O., & Oo, Y. H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.591380 · Cited by 32
Potential immunological effects of gender-affirming hormone therapy in transgender people – an unexplored area of research
White, A. A., Lin, A. P., Bickendorf, X., Cavve, B. S., Moore, J. K., Siafarikas, A., Strickland, D. H., & Leffler, J. (2022) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188221139612 · Cited by 33
Inflammation in preterm birth: Novel mechanism of preterm birth associated with innate and acquired immunity
Negishi, Y., Shima, Y., Katô, M., Ichikawa, T., Ino, H., Horii, Y., Suzuki, S., & Morita, R. (2022) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2022.103748 · Cited by 31
Raloxifene Suppresses Experimental Autoimmune Encephalomyelitis and NF-κB-Dependent CCL20 Expression in Reactive Astrocytes
Li, R., Xu, W., Chen, Y., Qiu, W., Shu, Y., Wu, A., Dai, Y., Bao, J., Lu, Z., & Hu, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094320 · Cited by 31
Influences of pregnancy on neuromyelitis optica spectrum disorders and multiple sclerosis
Tong, Y., Liu, J., Yang, T., Kang, Y., Wang, J., Zhao, T., Cheng, C., & Fan, Y. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.07.006 · Cited by 31
Multiple Sclerosis
Gaby, A. R. (2013) · Global Advances in Health and Medicine · doi:10.7453/gahmj.2013.2.1.009 · Cited by 31
Apolipoprotein E may be a critical factor in hormone therapy neuroprotection
Robert, G. S. (2008) · Frontiers in bioscience · doi:10.2741/3088 · Cited by 29
Pregnancy and multiple sclerosis
Airas, L. M., & Kaaja, R. (2012) · Obstetric Medicine · doi:10.1258/om.2012.110014 · Cited by 30
Multiple Sclerosis in Pregnancy
Coyle, P. K. (2014) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000443836.18131.c9 · Cited by 30
What immunological and hormonal protective factors lower the risk of COVID-19 related deaths in pregnant women?
Berhan, Y. (2020) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2020.103180 · Cited by 30

Authors: Sicotte, N. L., Liva, S. M., Klutch, R., Pfeiffer, P., Bouvier, S., Odesa, S., Wu, T. C. J., & Voskuhl, R. R.
Affiliations: University of California, Los Angeles (US)
Corresponding author: Voskuhl, Rhonda R.
ORCID: Sicotte, Nancy L.
Voskuhl, Rhonda R.
Venue: Annals of Neurology
Publisher: Wiley
Published: 2002-08-19
Volume: 52
Issue: 4
Pages: 421-428
ISSN: 0364-5134 (ISSN-L)
1531-8249
DOI: 10.1002/ana.10301
OpenAlex: W2135551891
Cited by: 435
References: 41
Citations by year: 2026: 7 · 2025: 8 · 2024: 10 · 2023: 13 · 2022: 13 · 2021: 9 · 2020: 14 · 2019: 12 · 2018: 22 · 2017: 11 · 2016: 24 · 2015: 19 · 2014: 30 · 2013: 25 · 2012: 30
FWCI: 12.95
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Annals of Neurology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
Keywords: multiple sclerosis, estriol, pregnancy hormones, relapsing-remitting multiple sclerosis, interferon-gamma, delayed-type hypersensitivity, gadolinium-enhancing lesions, disease-modifying therapy
MeSH terms: Adolescent, Adult, Estriol, Female, Humans, Hypersensitivity, Delayed, Magnetic Resonance Imaging, Middle Aged, Multiple Sclerosis, Pregnancy, Recurrence, Biomarkers, Th1 Cells, Cross-Over Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Treatment of multiple sclerosis with the pregnancy hormone estriol

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks